GlobeNewswire by notified

The INNOCN Ultrawide 40" Gaming Monitor 40C1R has Great Deals on Prime Day for Gamers and Photographers

Share

SHENZHEN, China, July 11, 2022 (GLOBE NEWSWIRE) -- The INNOCN team has been steadily improving the display monitor market since 2014. To its customers, Shenzhen Century Joint Innovation Technology Company Ltd. (INNOCN) is a manufacturer and distributor of high-quality monitors, commercial displays, and all-in-one computers. In order to consistently provide customers with a top-notch screen viewing experience, INNOCN has been able to produce high quality products through research and development carried out at its various production facilities.

To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

The INNOCN Ultrawide 40” Gaming Monitor 40C1R is one of the company's most recent monitors, and it is currently available on Amazon DEAmazon FR and Amazon ES. This monitor normally costs 639 EUR, but it will be discounted during Prime Day on July 12th-13th.

This widescreen monitor has 18 percent more viewable screen area than a 34-inch gaming monitor, a high resolution of 1440 pixels, and a 21:9 screen ratio for a superior wide screen visual that captures gaming detail more precisely than standard models with a 16:9 screen ratio.

The stunning visuals produced by this monitor make it ideal for live streaming content from services like YouTube TV, Netflix, Hulu, Starz, and many more. The high dynamic range technology in the Gaming Monitor 40C1R includes AMD FreeSync Premium, HDR 400, and a peak brightness of 500 nits. The monitor has features that support true natural color and low blue light to protect the eyes of game players and TV viewers. Users seeking productivity will find it in this monitor's split screen capabilities, which enable multitasking such as video editing and data analysis. It has USB C, DP, and HDMI ports so that users can connect any device at their leisure.

The INNOCN Gaming Monitor 40C1R is ideal for gamers, but it can also be useful for those who work from home. The viewing features are pleasant, allowing workers to feel at ease while examining reports and attending remote work meetings. This color gaming monitor is also ideal for photographers, as it provides excellent quality when editing photos for family portraits, weddings, graduations, and other events.

Prime Day Deals at INNOCN

Every year, Amazon hosts Prime Day, where Amazon Prime members from all over the world can shop for the best deals on electronics and other goods. On Prime Day, INNOCN will have some of the best deals around. The INNOCN 40" Ultrawide Gaming Monitor 40C1R will be available for only 511 EUR on July 12-13, a discount of 100 EUR from its regular price. Those who have been debating whether to purchase this best color gaming monitor should do so on Prime Day.

Media Contact

Manufacturer's Name: Shenzhen Century Joint Innovation Technology Company Limited

Manufacturer's Official Website: https://www.innocn.com/

Manufacturer's Email Address: marketing@innocn.com

A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/619737a6-258b-4271-ac49-595aac901e54

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

GXO Reports First Quarter 2024 Results7.5.2024 22:30:00 CEST | Press release

First quarter revenue of $2.5 billion, up 6% year over year; organic revenue growth1 of 1%Signed new business wins of approximately $250 million in annualized revenue in 1Q 2024; up 55% year over yearSales pipeline at 12-month high of $2.2 billionCompleted acquisition of Wincanton on April 29, 2024 GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2024. Malcolm Wilson, chief executive officer of GXO, said, “We delivered a strong start to 2024, reflecting our solid execution amid improving industry dynamics. The company grew revenue by 6% to $2.5 billion and delivered positive organic revenue growth, while gaining market share. We look forward to driving continued growth throughout 2024 and are on track to achieve our full-year outlook. “We’re seeing strengthening demand from global blue-chip customers to realize operational efficiencies today while planning fulfillment strategies to meet their future needs.

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update7.5.2024 22:30:00 CEST | Press release

Montrouge, France, May 7, 2024 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update VITESSE enrollment on track to screen last patient by Q3 2024Appointment of Robert Pietrusko, PharmD to Chief Regulatory OfficerQ1 2024 closes with a cash balance of $101.5 million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the first quarter 2024. The quarterly financial statements were approved by the Board of Directors on May 7, 2024. Recent Business Developments Clinical and Regulatory Update Enrollment for VITESSE, DBV’s Phase 3 pivotal study of the modified Viaskin Peanut patch in children ages 4 through 7 years with peanut allergy passed the halfway point for recruitment in Q1 and continues to be on track to screen the last patient by

SFL - Invitation to Presentation of Q1 2024 Results7.5.2024 22:19:00 CEST | Press release

SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the first quarter of 2024 on Tuesday, May 14, 2024. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, May 14, 2024, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at www.sflcorp.com. In order to listen to the conference call and presentation, you may do one of the following: A: Join Conference CallWebcast In Listen Only Mode: Visit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to "Webcast", or access directly via the webcast link below. The webcast with slideshow will be played live from this platform: SFL Corporation Ltd. Q1 2024 Webcast B: Join Conference Call AndParticipate in Live Q&AthroughZoom: Join through the Zoom link below to ask a question: SFL Q1 2024 Q&A Meeti

Oculis Publishes Invitation to the Annual General Meeting7.5.2024 22:05:00 CEST | Press release

Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST / 9:30 a.m. EDT. All information pertaining to the 2024 Annual General Meeting, including meeting materials, can be accessed on the Oculis website at https://investors.oculis.com/events-presentations. About Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior

Nokia Corporation: Repurchase of own shares on 07.05.20247.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 07 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 07.05.2024 Espoo, Finland – On 07 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL376,2023.48CEUX--BATE--AQEU--TQEX--Total376,2023.48 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye